Skip to main content
  • Hydroxychloroquine/Azithromycin Shows Prolonged QT Intervals, No Effect on Mortality in COVID-19

    An increase in corrected QT (QTc) intervals was seen in hospitalized COVID-19 patients treated with hydroxychloroquine/azithromycin (HCQ/AZM), but these changes were not associated with an increased risk of death, according to a study released Wednesday.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details